Abstract: . . .  13. HAUTMANN RE, DE PETRICONI R, GOTTFRIED HW, KLEINSCHMIDT K, MATTES R, PAISS T. The ileal neo- bladder : complications and functional results in 363 patients after 11 years of follow-up. J Urol 1999,161:422-7 14. KACHNIC L, KAUFMAN D, HENEY N. Bladder preser- vation by combined modality therapy for invasive bladder cancer . J Clin Oncol 1997, 15 : 1022-1029. 15. LAMM DL, BLUMENSTEIN B, CRISSMAN JD, MON- TIE JE, GOTTESMAN JE, LOWE BA, SAROSDY G, BOHL RD, GROSSMAN HB, BECK TM, LEIMERS JT, CRAWFORD ED. Maintenance BCG immunotherapy for recurrent Ta, T1 and TIS transitional cell carcinoma of the bladder : A randomized SWOG group study. J Urol 2000,163:1124-9 16. LEBRET T, HERVÉ JM, BARRÉ P, GUDEZ F, LUGAGNE PM, BARBAGELATTA M, BOTTO H. Urethral reccuren- ce of transitional cell carcinoma of the bladder. Eur Urol 1998,33:170-74 17. MALAVAUD B, VAESSEN C, MOUZIN M, RISCHMANN P, SARRAMON JP, SCHULMAN C. Complications for radical cystectomy. Impact of the American Society of Anesthesiologists score. Eur Urol 2001,39(1):79-84 18. RISCHMANN P, DESGRANDCHAMPS F, MALAVAUD B, CHOPIN D. BCG Intravesical Instillations : Recom- mandations for Side-Effects Management. Eur Urol 1999, 37, S1, 33-36 19. TOLLEY DA, PARMAR MKB, GRIGOR KM, LALLE- MAND G, BENYON LL, FELLOWS J, FREEDMAN LS, GRIGOR KN, HALL RR, HARGRAVE TB, MUNSON K, NEWLING DW, RICHAR B, ROBINSON MR, ROS MB, SMITH PH, WILLIC JL, WHELAN P. The effect of intra- vesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer : A further report with 7 years of follow-up. J Urol 1996,155 :1233-8 27  . . .
--3000,1,1500,1672,35722